Evotec Sets Empire Building Sights On Infectious Disease Space

As others shun anti-infectives, Evotec is consolidating its position. Through an alliance with Sanofi it is evaluating new anti-infectives in three areas, and expects soon to advance its first candidate therapeutic into the clinic.  

SC1808_Hamburg_750177721_1200.jpg
Hamburg, Germany, where Evotec is based. • Source: Shutterstock

More from Anti-infective

More from Therapy Areas